Associations Between Kidney Histopathologic Lesions and Incident Cardiovascular Disease in Adults With Chronic Kidney Disease

Abstract

ImportanceHistologic lesions in the kidney may reflect or contribute to systemic processes that may lead to adverse cardiovascular events.ObjectiveTo assess the association between kidney histopathologic lesion severity and the risk of incident major adverse cardiovascular events (MACE).Design, Setting, and ParticipantsThis prospective observational cohort study included participants without a history of myocardial infarction, stroke, or heart failure from the Boston Kidney Biopsy Cohort recruited from 2 academic medical centers in Boston, Massachusetts. Data were collected from September 2006 and November 2018, and data were analyzed from March to November 2021.ExposuresSemiquantitative severity scores for kidney histopathologic lesions adjudicated by 2 kidney pathologists, a modified kidney pathology chronicity score, and primary clinicopathologic diagnostic categories.Main Outcomes and MeasuresThe main outcome was the composite of death or incident MACE, which included myocardial infarction, stroke, and heart failure hospitalization. All cardiovascular events were independently adjudicated by 2 investigators. Cox proportional hazards models estimated associations of histopathologic lesions and scores with cardiovascular events adjusted for demographic characteristics, clinical risk factors, estimated glomerular filtration rate (eGFR), and proteinuria.ResultsOf 597 included participants, 308 (51.6%) were women, and the mean (SD) age was 51 (17) years. The mean (SD) eGFR was 59 (37) mL/min per 1.73 m2, and the median (IQR) urine protein to creatinine ratio was 1.54 (0.39-3.95). The most common primary clinicopathologic diagnoses were lupus nephritis, IgA nephropathy, and diabetic nephropathy. Over a median (IQR) of 5.5 (3.3-8.7) years of follow-up, the composite of death or incident MACE occurred in 126 participants (37 per 1000 person-years). Compared with the reference group of individuals with proliferative glomerulonephritis, the risk of death or incident MACE was highest in individuals with nonproliferative glomerulopathy (hazard ratio [HR], 2.61; 95% CI, 1.30-5.22; P = .002), diabetic nephropathy (HR, 3.56; 95% CI, 1.62-7.83; P = .002), and kidney vascular diseases (HR, 2.86; 95% CI, 1.51-5.41; P = .001) in fully adjusted models. The presence of mesangial expansion (HR, 2.98; 95% CI, 1.08-8.30; P = .04) and arteriolar sclerosis (HR, 1.68; 95% CI, 1.03-2.72; P = .04) were associated with an increased risk of death or MACE. Compared with minimal chronicity, greater chronicity was significantly associated with an increased risk of death or MACE (severe: HR, 2.50; 95% CI, 1.06-5.87; P = .04; moderate: HR, 1.66; 95% CI, 0.74-3.75; P = .22; mild: HR, 2.22; 95% CI, 1.01-4.89; P = .047) in fully adjusted models.Conclusions and RelevanceIn this study, specific kidney histopathological findings were associated with increased risks of CVD events. These results provide potential insight into mechanisms of the heart-kidney relationship beyond those provided by eGFR and proteinuria.

Clinical characteristics and 1-year all-cause mortality in elderly hip fracture patients with type 2 diabetes mellitus: a propensity score matching study

“…increase the heart burden 38 , and cause cardiac complications once decompensation 39 . (2) T2DM patients are often combined with renal function damage, resulting in a decrease in the kidneys' ability to regulate uid and acid-based balance 40 , which is easy to induce water, electrolyte and acid-base imbalance, and even interfere with myocardial electrical activity and cause serious complications such as arrhythmia 41 . (3) T2DM patients are more likely to have metabolic disorders such as blood glucose uctuations 42 and nutritional insu ciency during the perioperative period 43 , which will also increase the risk of perioperative complications.…”

The role of uromodulin in cardiovascular disease: a review

“…While much attention has been paid to its expression as a biomarker for kidney disease, recent years have witnessed a growing body of evidence linking uromodulin to cardiovascular events and mortality through numerous clinical and Mendelian randomization studies. This linkage is comprehensible given the recognized association between chronic kidney disease (CKD) and cardiovascular events ( 7 ), alongside the established role of uromodulin in salt-sensitive hypertension ( 8 ). Considering hypertension's status as a significant risk factor for various cardiovascular events ( 9 ), uromodulin emerges as a potential biomarker extending beyond renal function.…”

Linking Kidney Vessel Scarring to Cardiovascular Risk

“…To the Editor In their study of a native kidney biopsy cohort, Buckley et al demonstrate significant associations between histopathologic diagnoses as well as individual lesions and the risk of incident major adverse cardiovascular events during follow-up. These results highlight the relevance of kidney histopathology, notably intrarenal vessel scarring evaluation, as a valuable tool for refining cardiovascular risk assessment in patients with kidney disease in addition to traditional risk factors and usual descriptors, such as estimated glomerular filtration rate (eGFR) and proteinuria.…”